[Federal Register Volume 86, Number 170 (Tuesday, September 7, 2021)]
[Notices]
[Pages 50143-50144]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-19383]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Proposed Collection; 60-Day Comment Request: Federal COVID 
Response--Audience Feedback To Inform Ongoing Messaging and Strategies 
for ``Combat COVID''

AGENCY: National Institutes of Health, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: In compliance with the requirement of the Paperwork Reduction 
Act of 1995 to provide opportunity for public comment on proposed data 
collection projects, the National Institutes of Health (NIH), Clinical 
Center (CC) will publish periodic summaries of proposed projects to be 
submitted to the Office of Management and Budget (OMB) for review and 
approval.

DATES: Comments regarding this information collection are best assured 
of having their full effect if received within 60 days of the date of 
this publication.

FOR FURTHER INFORMATION CONTACT: To obtain a copy of the data 
collection plans and instruments, submit comments in writing, or 
request more information on the proposed project, contact: Ms. Mikia P. 
Currie, Office of Policy for Extramural Research Administration, 6705 
Rockledge Drive, Suite 350, Bethesda, Maryland 20892, or call a non-
toll free number (301) 435-0941 or Email your request, including your 
address to: [email protected]. Formal requests for 
additional plans and instruments must be requested in writing.

SUPPLEMENTARY INFORMATION: Section 3506(c)(2)(A) of the Paperwork 
Reduction Act of 1995 requires: written comments and/or suggestions 
from the public and affected agencies are invited to address one or 
more of the following points: (1) Whether the proposed collection of 
information is necessary for the proper performance of the function of 
the agency, including whether the information will have practical 
utility; (2) The accuracy of the agency's estimate of the burden of the 
proposed collection of information, including the validity of the 
methodology and assumptions used; (3) Ways to enhance the quality, 
utility, and clarity of the information to be collected; and (4) Ways 
to minimize the burden of the collection of information on those who 
are to respond, including the use of appropriate automated, electronic, 
mechanical, or other technological collection techniques or other forms 
of information technology.
    Proposed Collection Title: Federal COVID Response--Audience 
Feedback to Inform Ongoing Messaging and Strategies for ``Combat 
COVID,'' OMB #0925-0769, exp.12/31/2021, EXTENSION, National Institutes 
of Health (NIH).
    Need and Use of Information Collection: The purpose of the 
information collection is to collect routine feedback from the Combat 
COVID Initiative's two target audiences (the general public and 
healthcare providers) to identify evolving needs and better disseminate 
relevant information as it relates to COVID-19 treatment and ACTIV 
clinical trial resources, specifically. Data collected will be used to 
inform the development and broad dissemination of Combat COVID 
resources, including new or enhanced message and material concepts 
(e.g., social media ads, digital display ads, out-of-home ads), and/or 
web pages (combatcovid.hhs.gov). Because the COVID-19 treatment 
landscape continues to evolve, new evidence-based information continues 
to come to the forefront, and audience needs continue to change, it is 
critical for the Federal COVID Response (FCR) Team to collect quick 
audience feedback from the general public (especially from groups who 
have not historically been well-represented in clinical trials) and 
healthcare providers to identify these evolving needs. By understanding 
target audience needs, the FCR team will be able to properly develop 
and broadly disseminate relevant COVID-19 treatment and ACTIV clinical 
trial resources.
    OMB approval is requested for 1 year. There are no costs to 
respondents other than their time. The total estimated annualized 
burden hours are 3,528.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                     Number of     Average time
               Type of respondent                    Number of     responses per   per response    Total annual
                                                    respondents     respondent      (in hours)     burden hours
----------------------------------------------------------------------------------------------------------------
Consumer Audience Feedback Team Screener........             120               1            5/60              10
HCP Audience Feedback Team Screener.............              40               1            5/60               3

[[Page 50144]]

 
Consumer Audience Feedback Activity.............              60               8               1             480
HCP Audience Feedback Activity..................              20               8               1             160
Benchmark & Follow-Up Web Surveys--Consumer                2,000               5           15/60           2,500
 Audience.......................................
Benchmark & Follow-Up Web Survey--HCP Audience..             300               5           15/60             375
                                                 ---------------------------------------------------------------
    Total.......................................           2,540          12,300  ..............           3,528
----------------------------------------------------------------------------------------------------------------


    Dated: September 1, 2021.
Lawrence A. Tabak,
Principal Deputy Director, National Institutes of Health.
[FR Doc. 2021-19383 Filed 9-3-21; 8:45 am]
BILLING CODE 4140-01-P